Phio Pharmaceuticals Corp. - Nilai perusahaan marang pendapatan PHIO

Simbol resmi perusahaan Phio Pharmaceuticals Corp (PHIO)

Phio Pharmaceuticals is developing an immuno-oncology ecosystem, establishing an exclusive patent barrier through unique protocols. The price-to-sales multiple reflects the market reaction to these achievements, where 0.00 determines the latest valuation metric. Business scalability is based on the creation of high-margin RNA molecules, while the scientific pipeline is currently focused on clinical trials for solid tumor therapies.

Phio Pharmaceuticals (PHIO): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Phio Pharmaceuticals Corp - rincian analitis lan metrik utama (PHIO)

- kuotasi saiki lan rata-rata prakiraan nilai:
Pambiji fundamental perusahaan:Phio Pharmaceuticals
Produk sing diprodhuksi Phio Pharmaceuticals Corp.

This multiple determines the market value of the business minus net debt relative to sales volume, revealing the efficiency of asset monetization without the influence of debt load. By analyzing the enterprise value-to-revenue ratio of Phio Pharmaceuticals (PHIO), an investor can assess the resilience of this small-cap biotech in the face of patent dominance by RNA interference behemoths, where inflated valuations often mask risks of technological stagnation.

Analisis pesaing Phio Pharmaceuticals

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|SRPT: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Twist Bioscience|TXG (10x Genomics) - Nilai perusahaan marang pendapatan|Intellia Therapeutics, Inc. (NTLA) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Stoke Therapeutics Inc|BLFS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan WVE (Wave Life Sciences Corp)|Rasio total nilai perusahaan marang pendapatan Maze Therapeutics Corp|Sionna Therapeutics Inc - Nilai perusahaan marang pendapatan|PRME (primemedicine.com) - Nilai perusahaan marang volume dodolan|TSHA - Rasio nilai perusahaan marang pendapatan|QURE (uniQure) - Rasio nilai perusahaan marang pendapatan|MeiraGTx Corp (MGTX) - Rasio nilai perusahaan marang pendapatan|Regenxbio - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan solidbio.com|Multiplikator nilai perusahaan marang pendapatan ocugen.com OCGN|Multiplikator EV/Sales PACB|Benitec - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Design Therapeutics DSGN|Multiplikator EV/Sales Rocket Pharmaceuticals RCKT|Nilai perusahaan marang volume dodolan 4D Molecular Corp|LXEO: Rasio nilai perusahaan marang pendapatan|KRRO (Korro Bio, Inc) - Nilai perusahaan marang pendapatan|Editas Medicine (EDIT) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Silence Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan PRQR (proqr.com)|Rasio nilai perusahaan marang pendapatan Codexis Bio (CDXS)|Multiplikator EV/Sales sangamo.com (SGMO)|Rasio nilai perusahaan marang pendapatan nautilus.bio NAUT|Rasio total nilai perusahaan marang pendapatan Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Multiplikator EV/Sales|GBIO - Multiplikator EV/Sales|BOLD: Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan XCUR|Rasio nilai perusahaan marang pendapatan Imunon|mustangbio.com (MBIO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan TransCode (RNAZ)|Bionano Genomics Inc. - Rasio nilai perusahaan marang pendapatan|Applied DNA Sciences - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan bluebirdbio.com (BLUE)|IPA - Rasio nilai perusahaan marang pendapatan|OMGA - Multiplikator EV/Sales|OMIC (Singular Genomics Systems, Inc.) - Nilai perusahaan marang pendapatan|Regulus Therapeutics Inc - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Syros Pharmaceuticals|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan